JPRN-UMIN000008357已完成2 期
Combination of Gemcitabine and Paclitaxel for urothelial carcinoma - Gemcitabine and Paclitaxel for Urothelial carcinoma
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. prior chemotherapy with paclitaxel 2. patients with interstitial pneumoniae and pulmonary fibrosis 3. patients with body fluid with the necessity of drainage or severe edema 4. patients with brain metastasis with the necessity of treatment 5. active double cancer 6. severe or uncontrollable complications 7. patients with allergy to polyoxyethylene castor oil-contain drug (e.g., CDDP) or sclerosing castor oil-contain drug (e.g., injectable vitamins) 8. Not eligible for patients during Pregnancy or Lactation, and with the hope of pregnancy 9. Prior therapy is allowed if this is completed more than 28 days before study entry. 10. Otherwise, patients are judged to be not eligible by the attending doctor.
研究者
相似试验
未知
2 期
Phase II study of a combined Paclitaxel, Gemcitabine, and Cisplatin chemotherapy regimen for advanced urothelial carcinomaadvanced urothelial carcinomaJPRN-UMIN000001979Cancer Institute Hospital, Japanese Foundation for Cancer Research30
尚未招募
2 期
eoadjuvant Gemcitabine+nab-Paclitaxel for resectable and borderline resectable pancreatic cancer-feasibility study for the elderlyResectable and Borderline resectable pancreatic cancerJPRN-UMIN000048555Hyogo Prefectural Awaji Medical Center50
尚未招募
3 期
Assessment of prolongation of life with 2 different chemotherapy regimens - Gemcitabine – Cisplatin – Nab-Paclitaxel (GAP) and gemcitabine-platinum (GP) combination in advanced gallbladder cancers.CTRI/2024/01/061479Tata Memorial Centre
已完成
不适用
Preoperative gemcitabine plus nab-paclitaxel, concurrent 3D conformal radiation therapy for borderline resectable pancreatic cancer: Phase I studypancreatic cancerJPRN-UMIN000012456Department of Gastroenterological Surgery, Osaka Medical Center for Cancer & Cardiovascular Diseases42
招募中
2 期
Preoperative gemcitabine plus nab-paclitaxel, concurrent 3D conformal radiation therapy for resectable pancreatic cancer: Phase II studypancreatic cancerJPRN-UMIN000018803Department of Gastroenterological Surgery, Osaka Medical Center for Cancer & Cardiovascular Diseases50